Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-02-03

FDA Approved: LAMIVUDINE AND ZIDOVUDINE — Original Application (Exelan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a generic lamivudine and zidovudine combination tablet under an original ANDA for Exelan Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamivudine and Zidovudine (Lamivudine and Zidovudine)

Snippet

ORIG AP for LAMIVUDINE AND ZIDOVUDINE (LAMIVUDINE AND ZIDOVUDINE)